Comments
Gujarat-based Eris Lifesciences’ existing shareholders plans to offer 2.89 crore shares in the price band of ₹600-603 through an IPO, which will open on June 16 and close on June 20.
The number of shares offered includes 2.2 crore shares, or 16.25 per cent stake held by PE giant ChrysCapital’s investment arm Botticelli. The remaining stake is to be sold by founder Amit Bakshi and other investors, including Himanshu Shah and Rakesh Shah, among others. Bids can be made for a minimum of 24 equity shares.
Eris develops, manufactures and commercialises branded pharma products in select therapeutic areas within the chronic and acute categories, which are linked to lifestyle-related disorders.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.